A multidisciplinary team of scientists from the National University of Singapore (NUS) has developed an artificial intel...
Singapore – Lucence Diagnostics, a genomic medicine company focused on inventing advanced cancer diagnostics, and ...
Oliver™ Healthcare Packaging, a leading provider of sterile barrier flexible packaging for the global healthcare i...
Singapore – In the near future, doctors may be able to diagnose and treat patients’ physical and mental...
Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanize...
A Memorandum of Understanding was signed by Tan Tock Seng Hospital (TTSH)'s Centre for Asian Nursing Studies (CANS), the...
A research team led by scientists from the Cancer Institute of Singapore (CSI Singapore) at the National University of S...
Singapore – Only three years after its official launch in 2015, the Asia Pacific Medical Technology Associati...
Japan's Chugai Pharma has announced that it has decided to expand the business of Chugai Pharmabody Research, its ...
Lucence Diagnostics will be partnering with the National Cancer Centre Singapore (NCCS) on a study to improve genetic te...
PharmaJet®, the maker of innovative, needle-free injection technology, and Mundipharma announced an exclusive partne...
Zecotek Photonics Inc. a developer of leading-edge photonics technologies for healthcare, industrial and scientific mark...
Singapore - Healthway Medical Corporation (HMC) Limited announced a refreshed look and tagline to compl...
Singapore – Around 1.5 million people have had their personal details stolen in a cyber-attack on the Singapore go...
Singapore – Singaporeans’ urban lifestyle is a silent killer. Rapid industrialisation and urbanisation over ...
Ascletis Pharma, the first biotechnology firm to file for an IPO in Hong Kong following recent listing reforms, has secu...
Singapore- AWAK Technologies (AWAK), a pioneering medical technology company focused on dialysis using regeneration tech...
The Health Sciences Authority has approved Novartis Kisqali (Ribociclib, LEE011), earlier this year as a first-line trea...
